Delisting risk
Humacyte
Commercializing Symvess while expanding its ATEV vessel platform.
$0.6557
After-hours close+0.01 (+0.83%)
At close$0.6503(−6.12%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.09 | — | — |
| Aug 2026 | −$0.11 | −$0.16 | −41.0% |
| May 2026 | −$0.10 | −$0.09 | +10.0% |
| Mar 2026 | −$0.13 | −$0.13 | 0.0% |
| Nov 2025 | −$0.17 | −$0.14 | +17.6% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.09 | — | — | $769.4K | — | — |
| Aug 12, 2026 | −$0.11 | −$0.16 | −41.0% | $1.0M | $406.0K | −61.0% |
| May 13, 2026 | −$0.10 | −$0.09 | +10.0% | $1.5M | $495.0K | −66.2% |
| Mar 27, 2026 | −$0.13 | −$0.13 | 0.0% | $1.3M | $467.0K | −65.4% |
| Nov 12, 2025 | −$0.17 | −$0.14 | +17.6% | $1.3M | $753.0K | −44.2% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | ||||||
| Aug 11, 2025 | ||||||
| May 13, 2025 | ||||||
| Mar 28, 2025 | ||||||
| Nov 8, 2024 | ||||||
| Aug 13, 2024 | ||||||
| May 10, 2024 | ||||||
| Mar 22, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 14, 2023 | ||||||
| May 12, 2023 | ||||||
| Mar 24, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 12, 2022 | ||||||
| May 13, 2022 | ||||||
| Mar 29, 2022 | ||||||
| Nov 12, 2021 | ||||||
| Aug 16, 2021 | ||||||
| May 17, 2021 | ||||||
| Feb 16, 2021 | ||||||
| Nov 12, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||